Axxcess Wealth Management
SLS icon

Axxcess Wealth Management’s SELLAS Life Sciences SLS Stock Holding History

Axxcess Wealth Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$515K Buy
41,874
+501
+1% +$6.28K 0.02% 563
2026
Q2 		$611K Buy
41,373
+6,003
+17% +$41.4K 0.01% 660
2026
Q1 		$150K Hold
35,370
– – ﹤0.01% 368
2025
Q4 		$133K Buy
35,370
+19,370
+121% +$37.6K ﹤0.01% 1015
2025
Q3 		$25.8K Buy
+16,000
New +$28.5K ﹤0.01% 923

Other funds holding SLS

DI
DAGCO Inc Westlake, Ohio $576M AUM 21.79% 1-Year Est. Return
Everhart Financial Group
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Fulcrum Wealth Advisors
Fulcrum Wealth Advisors Bellevue, Washington $144M AUM 21.17% 1-Year Est. Return
Accurate Wealth Management
Accurate Wealth Management Wesley Chapel, Florida $1.16B AUM 24.67% 1-Year Est. Return
Instrumental Wealth
Instrumental Wealth Tampa, Florida $206M AUM 16.83% 1-Year Est. Return
Genesee Capital Advisors
Genesee Capital Advisors Auburn, New York $318M AUM 26.07% 1-Year Est. Return
ELCO Management
ELCO Management New York $213M AUM 25.23% 1-Year Est. Return
Independent Financial Group
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return
Martin Capital Advisors
Martin Capital Advisors San Antonio, Texas $193M AUM 34.04% 1-Year Est. Return

Axxcess Wealth Management's SLS Position: Q3 2026 in Review

Axxcess Wealth Management increased its SELLAS Life Sciences (SLS) stake by 1.2% in Q3 2026, buying an estimated $6.28K and bringing the position to 41,874 shares worth $515K. The position accounts for 0.02% of the portfolio, ranked #563.

Axxcess Wealth Management first reported a position in SLS in Q3 2025 and has held it in 5 quarters since. The position peaked at $611K in Q2 2026. 26 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Axxcess Wealth Management held 41,874 shares of SELLAS Life Sciences worth $515K as of Q3 2026.
  • Axxcess Wealth Management bought 501 SELLAS Life Sciences shares in Q3 2026, an estimated $6.28K.
  • SELLAS Life Sciences made up 0.02% of Axxcess Wealth Management's portfolio in Q3 2026, its #563 holding.
  • Axxcess Wealth Management first reported a position in SELLAS Life Sciences in Q3 2025 and has held it in 5 quarters since.
  • Axxcess Wealth Management's SELLAS Life Sciences position peaked at $611K in Q2 2026.
  • 26 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Axxcess Wealth Management's 13F filing for Q3 2026, filed 21 Oct 2026.